US OptionsDetailed Quotes
NKTX250516C7500
- 0.75
- 0.000.00%
15min DelayClose May 2 16:00 ET
0.00High0.00Low
0.75Open0.75Pre Close0 Volume15 Open Interest7.50Strike Price0.00Turnover931.44%IV294.74%PremiumMay 16, 2025Expiry Date0.00Intrinsic Value100Multiplier13DDays to Expiry0.75Extrinsic Value100Contract SizeAmericanOptions Type0.5539Delta0.1088Gamma2.79Leverage Ratio-0.0579Theta0.0001Rho1.54Eff Leverage0.0015Vega
Nkarta Stock Discussion
Sign in to post a comment
$Nkarta (NKTX.US)$ down to 1.6-1.8 tomorrow, sold today , buy the dip next week.
1
$Nkarta (NKTX.US)$ going no where...lol
$Nkarta (NKTX.US)$
I saw $11 $14 and $18, whichever it is, i know you are going up. Just a matter of time..
I saw $11 $14 and $18, whichever it is, i know you are going up. Just a matter of time..
4
1
$Gorilla Technology (GRRR.US)$ PR: CEO will have interview with Red Chip Small Stock, Big Money show on Sat Dec 14. Reports on CEO on X that they have been selected from the shortlist for the $438M deal in SE Asia. Low float. $23.2M cash good for 12 months
$Checkpoint Therapeutics (CKPT.US)$ $Fortress Biotech (FBIO.US)$ FDA approval of drug for metastatic cutaneous squamous cell carcinoma. This drug is the first and only progr...
$Checkpoint Therapeutics (CKPT.US)$ $Fortress Biotech (FBIO.US)$ FDA approval of drug for metastatic cutaneous squamous cell carcinoma. This drug is the first and only progr...
31
31
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
$Nkarta (NKTX.US)$
Nkarta | SC 13G: Statement of acquisition of beneficial ownership by individuals-Kenneth Griffin(5.4%),Citadel Advisors LLC(4.5%), etc.
Nkarta | SC 13G: Statement of acquisition of beneficial ownership by individuals-Kenneth Griffin(5.4%),Citadel Advisors LLC(4.5%), etc.
No comment yet
股市捕快 OP : Today has increased too much, tomorrow there will be a correction.